| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Oric Pharmaceuticals, Inc. (ORIC) has 8 insiders with recent SEC Form 4 filings, including 2 buys and 10 sells. ORIC is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 213.1K | $1.89M | - | |
| CEO | 112.5K | $995.6K | - | |
| Dir | 40.0K | $354.0K | - | |
| Dir | 40.0K | $354.0K | - | |
| Dir | 40.0K | $354.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 18, 2021 | Orbimed Advisors LLC67 | Director | Sell | 66,202 | $27.95 | $1,850,338.63 | -0.9% | -29.1% | -74.7% | |
| Mar 15, 2021 | Orbimed Advisors LLC67 | Director | Sell | 238,282 | $30.54 | $7,275,985.53 | -2.9% | -30.5% | -78.4% | |
| Mar 15, 2021 | Gordon Carl L74 | Director | Sell | 238,282 | $30.54 | $7,275,985.53 | -2.9% | -30.5% | -78.4% | |
| Nov 4, 2020 | Topspin Fund L.P. | 10% Owner | Sell | 2,268,750 | $0.00 | - | -67.3% | - | - | |
| Apr 24, 2020 | Orbimed Advisors LLC67 | Director, 10% Owner | Buy | 281,250 | $16.00 | $4,500,000.00 | New | - | - | |
| Apr 24, 2020 | Gordon Carl L74 | Director, 10% Owner | Buy | 281,250 | $16.00 | $4,500,000.00 | New | - | - |